What happened?
Shares of healthcare technology company GE HealthCare Technologies (NASDAQ: GEHC) jumped 7.2% in the morning session after the company delivered third-quarter 2026 financial results that exceeded its expectations and raised its full-year guidance.
According to a company press release, GE HealthCare reported that revenue rose 7.2% and organic revenue climbed 6.2%, buoyed by 4.0% organic orders growth, a 1.03 times book-to-bill ratio, and a $23.7 billion backlog. Profitability expanded, with net income margin reaching 11.1% and adjusted EBIT margin finishing at 16.6%.
Diluted earnings per share surged 39.1% to $1.36, while adjusted earnings per share increased 25.1% to $1.34. The company generated $907 million in operating cash flow and $793 million in free cash flow. The raised full-year outlook and expanding backlog underscored durable demand for healthcare equipment, bolstering market confidence in the company's financial momentum.
Is now the time to buy GE HealthCare? Access our full analysis report here, it’s free.
What is the market telling us
GE HealthCare’s shares are not very volatile and have only had 5 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 3 months ago when the stock gained 11% on the news that the company reported second-quarter 2026 results that surpassed Wall Street's expectations for both revenue and profit.
The company posted revenue of $5.30 billion, up 5.8% year-over-year, and an adjusted profit of $1.13 per share, beating consensus estimates by 0.5% and 9.1%, respectively. Management also reaffirmed its full-year earnings guidance, which analysts noted was slightly ahead of expectations. Another positive sign was the improvement in free cash flow, which clocked in at $68 million, a significant increase from the same quarter last year. The strong quarterly performance, highlighted by the earnings beat, appeared to boost investor confidence.
GE HealthCare is down 7.8% since the beginning of the year, and at $76.34 per share, it is trading 13.4% below its 52-week high of $88.16 from January 2026. Investors who bought $1,000 worth of GE HealthCare’s shares at the IPO in December 2022 would now be looking at an investment worth $1,272.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
